1990 to 2019 Saw Increase in Global Burden of CVD
FRIDAY, Dec. 11, 2020 -- From 1990 to 2019, there was an increase in the burden of cardiovascular disease (CVD) globally, according to a study published online Dec. 9 in the Journal of the American College of Cardiology.
Gregory A. Roth, M.D., M.P.H., from the University of Washington in Seattle, and colleagues used data from the Global Burden of Disease Study 2019 to examine the incidence, prevalence, case fatality, mortality, and health risks associated with CVD for 204 countries and territories from 1990 to 2019.
The researchers found that prevalent cases of total CVD increased from 271 million in 1990 to 523 million in 2019, and the number of CVD deaths increased from 12.1 to 18.6 million, respectively. Significant increases were also seen in global trends for disability-adjusted life years (DALYs) and years of life lost; years lived with disability increased from 17.7 million to 34.4 million. From 1990, there was a steady increase in the total number of DALYs due to ischemic heart disease, reaching 182 million DALYs, 9.14 million deaths, and 197 million prevalent cases in 2019. For stroke, the total number of DALYs increased steadily from 1990, reaching 143 million DALYs, 6.55 million deaths, and 101 million prevalent cases of stroke in 2019.
"Renewed focus is needed now on affordable, widely available, and proven-effective implementation strategies for the prevention, treatment and control of CVD and risk factors, and the promotion of ideal cardiovascular health beginning in childhood," a coauthor said in a statement.
Several authors disclosed financial ties to the pharmaceutical and medical technology industries.
© 2021 HealthDay. All rights reserved.
Posted: December 2020
Read this next
WEDNESDAY, Jan. 27, 2021 -- Exercise-based cardiac rehabilitation (CR) can improve cardiovascular endurance and health status among stroke survivors, according to a study...
WEDNESDAY, Jan. 27, 2021 -- Heart disease remains the leading cause of death worldwide, with 18.6 million deaths attributed to cardiovascular disease (CVD) globally in 2019,...
TUESDAY, Jan. 26, 2021 -- For patients taking angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin II receptor blockers (ARBs) and hospitalized with mild-to-moderate...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.